Sign in

CIK 0001604191

  • Non-accelerated filer
  • Smaller reporting company

GridAI Technologies Corp.

Sign in to watch
Ticker
GRDX
Exchange
Nasdaq
Industry
Electric & Other Services Combined
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464993860
Phone
+1 561-589-7020
Business address
433 PLAZA REAL, SUITE 275, BOCA RATON, FL
Former names
Entero Therapeutics, Inc., First Wave BioPharma, Inc., AzurRx BioPharma, Inc., BioPharma d'Azur, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-07-02 SAPIRSTEIN JAMES Chairman and CEO Sale −1,289 $1.07 $1K 35,816
2024-04-01 SAPIRSTEIN JAMES Chairman and CEO Sale −174 $4.23 $736 37,105
2024-03-15 SAPIRSTEIN JAMES Chairman and CEO Sale −1,887 $4.96 $9K 37,279
2024-01-12 SAPIRSTEIN JAMES Chairman, President and CEO Sale −166 $4.20 $697 39,166
2024-01-02 SAPIRSTEIN JAMES Chairman, President and CEO Grant or award +20,000 39,332
2023-12-29 SAPIRSTEIN JAMES Chairman, President and CEO Grant or award +17,660 19,332
2023-10-04 SAPIRSTEIN JAMES President and CEO Sale −2,764 $0.29 $802 33,397
2023-07-03 SAPIRSTEIN JAMES President and CEO Sale −3,349 $1.54 $5K 36,161
2023-04-03 SAPIRSTEIN JAMES President and CEO Sale −3,347 $2.50 $8K 39,510
2023-01-03 SAPIRSTEIN JAMES President and CEO Grant or award +300,000 300,000
2022-01-03 SAPIRSTEIN JAMES PRES, CEO & CHAIRMAN OF BOARD Grant or award · Stock option (right to buy) +150,000 150,000
2021-06-30 SAPIRSTEIN JAMES PRES, CEO & CHAIRMAN OF BOARD Other disposition · Stock options (right to buy) −900,000 300,000
2021-06-30 SAPIRSTEIN JAMES PRES, CEO & CHAIRMAN OF BOARD Grant or award · Stock options (right to buy) +900,000 900,000
2020-07-16 SAPIRSTEIN JAMES PRESIDENT AND CEO Grant or award · Stock options (right to buy) +1,200,000 1,200,000
2020-07-16 SAPIRSTEIN JAMES PRESIDENT AND CEO Grant or award · Series B Convertible Preferred Stock +12.99 12.99
2020-07-16 SAPIRSTEIN JAMES PRESIDENT AND CEO Grant or award · Series B Warrants +64,935 64,935
2019-10-08 SAPIRSTEIN JAMES PRESIDENT AND CEO Grant or award +200,000 200,000
2019-10-08 SAPIRSTEIN JAMES PRESIDENT AND CEO Grant or award · Options +300,000 300,000

Page 1 of 1 · 18 trades